Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Whitehawk Therapeutics (WHWK) Revenue: 2018-2025

Historic Revenue for Whitehawk Therapeutics (WHWK) over the last 4 years, with Mar 2025 value amounting to $7.1 million.

  • Whitehawk Therapeutics' Revenue rose 33.48% to $7.1 million in Q1 2025 from the same period last year, while for Mar 2025 it was $27.8 million, marking a year-over-year increase of 16.51%. This contributed to the annual value of $26.0 million for FY2024, which is 6.69% up from last year.
  • Whitehawk Therapeutics' Revenue amounted to $7.1 million in Q1 2025, which was down 1.30% from $7.2 million recorded in Q4 2024.
  • Whitehawk Therapeutics' Revenue's 5-year high stood at $14.0 million during Q4 2021, with a 5-year trough of -$227,000 in Q2 2021.
  • Over the past 3 years, Whitehawk Therapeutics' median Revenue value was $6.2 million (recorded in 2023), while the average stood at $6.4 million.
  • Per our database at Business Quant, Whitehawk Therapeutics' Revenue tumbled by 167.97% in 2021 and then surged by 2,803.82% in 2022.
  • Over the past 5 years, Whitehawk Therapeutics' Revenue (Quarterly) stood at $14.0 million in 2021, then crashed by 62.66% to $5.2 million in 2022, then climbed by 21.03% to $6.3 million in 2023, then increased by 14.43% to $7.2 million in 2024, then spiked by 33.48% to $7.1 million in 2025.
  • Its last three reported values are $7.1 million in Q1 2025, $7.2 million for Q4 2024, and $7.2 million during Q3 2024.